About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ENDRA Life Sciences Inc. - Common Stock (NQ:NDRA)

6.030 -0.370 (-5.78%)
Streaming Delayed Price Updated: 10:30 AM EDT, Apr 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ENDRA Life Sciences Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
ENDRA Life Sciences: Q2 Earnings Insights ↗
  ENDRA Life Sciences (NASDAQ:NDRA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 79 companies reached new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 64 companies achieved new lows for the year. 
Via Benzinga
News headline image
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 14, 2022 ↗
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
News headline image
ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday ↗
Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion. 
Via Benzinga
News headline image
ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
  
Via Benzinga
News headline image
ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Earnings Scheduled For August 15, 2022 ↗
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
News headline image
Preview: ENDRA Life Sciences Earnings ↗
  ENDRA Life Sciences (NASDAQ:NDRA) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. 
Via Benzinga
News headline image
ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS® System
From ENDRA Life Sciences
Via Business Wire
News headline image
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
News headline image
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday ↗
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
News headline image
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent
From ENDRA Life Sciences Inc.
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.